| 000 | 01849 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518014803.0 | ||
| 264 | 0 | _c20190422 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1665-2681 | ||
| 024 | 7 |
_a10.5604/01.3001.0012.7197 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAntwi, Samuel O | |
| 245 | 0 | 0 |
_aResponse to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma. _h[electronic resource] |
| 260 |
_bAnnals of hepatology _cOct 2018 |
||
| 300 |
_a969-979 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBile Duct Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCholangiocarcinoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplasms, Complex and Mixed _xdiagnostic imaging |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aProgression-Free Survival |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Burden |
| 700 | 1 | _aHabboush, Yacob Y | |
| 700 | 1 | _aChase, Lori A | |
| 700 | 1 | _aLee, David D | |
| 700 | 1 | _aPatel, Tushar | |
| 773 | 0 |
_tAnnals of hepatology _gvol. 17 _gno. 6 _gp. 969-979 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5604/01.3001.0012.7197 _zAvailable from publisher's website |
| 999 |
_c29212191 _d29212191 |
||